Clincosm LogoSign in Get a demo

Glioblastoma Multiforme

Showing NaN - NaN of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)

Recruiting
  • Glioblastoma Multiforme
  • Dichloroacetate (DCA)
  • Genotype
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 26, 2022

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Glioblastoma Multiforme, Brain Tumors Trial in United States (OncoGel (ReGel/Paclitaxel))

Terminated
Has Results
  • Glioblastoma Multiforme
  • Brain Neoplasms
  • OncoGel (ReGel/Paclitaxel)
  • Chicago, Illinois
  • +4 more
Jun 2, 2022

Glioblastoma Multiforme Trial in Washington, Baltimore (Temozolomide)

Completed
  • Glioblastoma Multiforme
  • Washington, District of Columbia
  • +2 more
Nov 17, 2021

Glioblastoma Multiforme Trial in Washington, Baltimore, Bethesda (Temozolomide, Subventricular Zone radiation, Neural Progenitor

Recruiting
  • Glioblastoma Multiforme
  • Washington, District of Columbia
  • +2 more
Sep 17, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Chicago, Baltimore, Saint Paul (PAC-1 Compound)

Suspended
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • PAC-1 Compound
  • Chicago, Illinois
  • +2 more
Sep 18, 2020

Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor

Terminated
  • Glioblastoma
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020

Glioblastoma Multiforme Trial in Baltimore, Winston-Salem (Diet modification)

Completed
  • Glioblastoma Multiforme
  • Diet modification
  • Baltimore, Maryland
  • +1 more
May 8, 2020

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)

Terminated
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Toca 511
  • +4 more
  • Phoenix, Arizona
  • +66 more
Feb 6, 2020

Glioblastoma Multiforme Trial in Baltimore (Radiation, Chemotherapy)

Completed
Has Results
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 11, 2019

Glioblastoma Multiforme Trial in United States (poly ICLC, temozolomide, radiation therapy)

Completed
Has Results
  • Glioblastoma Multiforme
  • poly ICLC
  • +2 more
  • Birmingham, Alabama
  • +8 more
May 30, 2019

Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)

Suspended
  • Glioblastoma Multiforme
  • ICT-107
  • Placebo
  • Birmingham, Alabama
  • +64 more
Aug 9, 2018

Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)

Completed
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +88 more
Apr 7, 2017

Glioblastoma Multiforme Trial in United States (ICT-107, Placebo DC)

Completed
Has Results
  • Glioblastoma Multiforme
  • ICT-107
  • Placebo DC
  • South Birmingham, Alabama
  • +24 more
Feb 10, 2017

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (IL13-PE38QQR, targeted fusion protein

Completed
  • Malignant Glioma
  • +3 more
  • Birmingham, Alabama
  • +7 more
Nov 12, 2014

Glioblastoma Multiforme Trial in Worldwide (IL13-PE38QQR, surgery and catheter placement (2 procedures), prolifespan 20 with

Completed
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +59 more
Jun 2, 2011

Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131I-TM601)

Unknown status
  • Malignant Glioma
  • +4 more
  • Chicago, Illinois
  • +3 more
Jul 16, 2009

Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)

Unknown status
  • Malignant Glioma
  • +5 more
  • Birmingham, Alabama
  • +18 more
Apr 1, 2009

Glioblastoma Multiforme Trial in Australia, United States (TransMID™)

Withdrawn
  • Glioblastoma Multiforme
  • La Jolla, California
  • +24 more
Jan 6, 2009